EPHA2 and cancer: We performed RT-qPCR and confirmed the differential expression of several cancer driver genes (23): increased mRNA expression of oncogenes MYC and PIK3CG, as well as decreased expression of tumor suppressor genes CDKN1A and EPHA2, was observed in the H2BE76K mutant cells (Fig. 3C).